CompaniesCommoditiesChemicalsChemicals & Petrochemicals
NSE:KRONOX

KRONOX LAB SCIENCES LTD

Chemicals › Chemicals & Petrochemicals
176.50
at close · 21 Sept 2026
2.55 (+1.47%)

Latest filings

  1. 17th AGM results: all 4 resolutions passed; Rs 0.50 dividend declared · Board & Shareholder Meetings
  2. AGM results: all 4 resolutions passed, dividend of Rs 0.50 per share declared · Compliance
  3. Kronox Lab Sciences 17th AGM: Final Dividend of Rs 0.50 Per Share Declared · Board & Shareholder Meetings
  4. Kronox Lab Sciences: Indo Borax open offer DLOF filed at Rs 157.27 per share · Strategic Transactions
  5. Indo Borax files Draft Letter of Offer for open offer on Kronox Lab · Strategic Transactions
  6. Newspaper publication of 17th AGM notice for September 16, 2026 meeting · Compliance
  7. Open Offer at Rs 157.27 per share by Indo Borax for 25.79% stake in Kronox · Strategic Transactions
  8. Open Offer by Indo Borax for Kronox Lab Sciences at Rs 157.27 per share · Strategic Transactions
  9. Record date fixed at Sept 9, 2026 for Rs 0.50 final dividend per share · Corporate Actions
  10. KRONOX Lab Sciences 17th AGM notice filed, dividend of Rs 0.50 per share · Board & Shareholder Meetings
  11. Corrigendum to FY26 Annual Report filing; 17th AGM on Sep 16, 2026 · Compliance
  12. Annual Report FY2025-26 and Notice of 17th AGM on September 16, 2026 · Board & Shareholder Meetings
  13. Open offer by Indo Borax at Rs 157.27 per share for 25.79% stake in Kronox Lab · Strategic Transactions
  14. Open Offer by Indo Borax at Rs 157.27 per share · Strategic Transactions
  15. Indo Borax to acquire 64.26% stake in Kronox Lab Sciences · Strategic Transactions
  16. Promoters sell 64.26% stake to Indo Borax Chemicals; open offer triggered · Strategic Transactions
  17. Promoters to sell 64.26% stake to Indo Borax and Chemicals; open offer triggered · Strategic Transactions
  18. Kronox Lab Q1 FY27 results: PAT up 38% YoY, revenue grows 17% · Results
  19. Board meeting on Aug 12 2026 to approve Q1 FY27 results · Results
  20. Clarification on unusual share volume movement · Regulatory & Legal
  21. BSE seeks clarification on volume movement from Kronox Lab Sciences · Regulatory & Legal
  22. NSE flags sharp jump in Kronox Lab trading volume; awaits company reply · Regulatory & Legal
  23. Routine filing of dematerialization certificate for quarter ended June 2026 · Compliance
  24. Kronox Lab files quarterly compliance certificate with depositories · Compliance
  25. Trading window closes July 1 ahead of Q1 results · Compliance
  26. Trading Window Closure for Q1 FY27 Results · Compliance
  27. Kronox Lab Sciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. · Ownership Changes
  28. Submission of Annual Secretarial Compliace Report for the Year ended March, 2026 · Compliance
  29. Kronox Lab Sciences Limited has informed the Exchange about Copy of Newspaper Publication · Compliance
  30. Newapaper publication for Audited Financial Results for the Quarter and Year ended March 31, 2026 · Compliance
  31. Kronox Lab Sciences Limited has informed the Exchange that Board of Directors at its meeting held on May 21, 2026, recommended Final Dividend of Rs. 0.5 per equity share. · Results
  32. Kronox Lab Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. · Results
  33. Board Meeting held today to consider and approve Audited Standalone Financial Results for the Quarter and Year ended on March 31, 2026 · Results
  34. Outcome of Board Meeting held today to consider and approve Audited Standalone Financial Results and Dividend · Results
  35. Kronox Lab Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve Audited Standalone Financial .... · Results
  36. Kronox Lab Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve Audited Financial Results .... · Results
  37. Significant movement in price has been observed in Kronox Lab Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Kronox Lab Sciences Limited has submitted their response. · Compliance
  38. Significant movement in price has been observed in Kronox Lab Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. · General
  39. Kronox Lab Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 · Compliance
  40. Closure of Trading window for the Quarter and Year ending March 31, 2026 · Compliance
  41. Kronox Lab Sciences Limited has informed the Exchange about Copy of Newspaper Publication · Compliance
  42. Kronox Lab Sciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. · Results
  43. Kronox Lab Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Un- audited Financial Results .... · Results
  44. Kronox Lab Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 · Compliance
  45. Kronox Lab Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 · Compliance
  46. Kronox Lab Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 · Compliance
  47. Kronox Lab Sciences Limited has informed the Exchange about Copy of Newspaper Publication · Compliance
  48. Kronox Lab Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. · Results
  49. Kronox Lab Sciences Limited has informed the Exchange regarding Board meeting held on November 11, 2025. · Board & Shareholder Meetings
  50. Kronox Lab Sciences Limited has informed the Exchange regarding 'UPDATE ON DEVELOPMENT STATUS OF UNIT-IV'. · Capex & Operations
All filings ↓
Ask Nexa about KRONOX LAB SCIENCES LTD

Snapshot

What the business is, and whether it's a good one at a fair price.

A Chemicals & Petrochemicals company listed on NSE and BSE, reporting revenue of ₹105 Cr over the trailing twelve months.

Market Cap
₹655 Cr
P / E (TTM)
22.7×
EV / EBITDA
16.0×
Div Yield
0.28%
Growth
·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
31.9%
ROCE (5y median)
ROE 23.8% · margin 39.0%
Leverage
0.01·
Debt / Equity · low
Net debt ₹-1 Cr
Revenue FY24→FY26
1.1×
Margin +3.6 pts
₹90 Cr → ₹101 Cr
Cash conversion
0.99×·
Operating cash ÷ profit · 3 yrs
₹74 Cr on ₹74 Cr
Moves on a normal day
1.45%·
Median daily move
Last 268 sessions · filing days run larger
Where it sits among 107 Specialty Chemicals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#51/104
P/B#78/99
ROCE#6/108
ROE#6/101
Debt / Equity#24/101
EBITDA margin#5/99
Revenue growth#63/94
Profit growth#63/92

Scorecard

Measured from the filed financials, judged against its Specialty Chemicals peers · as of FY26 — not investment advice

Strengths
Returns on capital 31.9%
#6 of 108 in Specialty Chemicals on the latest reported figures
Debt at 0.01× equity
lower than 77% of its 101 Specialty Chemicals peers
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

KRONOX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from KRONOX LAB SCIENCES LTD's filed financials and exchange disclosures

What does KRONOX LAB SCIENCES LTD do?

KRONOX LAB SCIENCES LTD is a Chemicals & Petrochemicals company listed on NSE and BSE, trading under the symbol KRONOX.

Is KRONOX LAB SCIENCES LTD profitable?

Yes. Over the trailing twelve months KRONOX LAB SCIENCES LTD reported a net profit of ₹29 Cr on revenue of ₹105 Cr.

Does KRONOX LAB SCIENCES LTD pay a dividend?

Yes. The dividend yield is 0.28% at the current price. It paid out 7% of its profit as dividend in FY26.

Is KRONOX LAB SCIENCES LTD debt-free?

Effectively yes. It holds ₹1 Cr more cash than debt. Debt stands at 0.01× equity.

Is KRONOX LAB SCIENCES LTD expensive compared with its peers?

On trailing P/E, KRONOX LAB SCIENCES LTD ranks 51 of 104 in Specialty Chemicals — cheaper than 52% of them, against an industry median of 23.7×. This is a position, not a valuation judgement.

How much does the KRONOX LAB SCIENCES LTD share price move in a day?

On a typical session KRONOX LAB SCIENCES LTD moves 1.45% — that is the median absolute close-to-close move across its last 268 trading days. Announcement days are routinely larger.

Where can I track KRONOX LAB SCIENCES LTD's announcements?

Every NSE and BSE filing by KRONOX LAB SCIENCES LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.